Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Patients often report reduced hunger, smaller meal sizes, fewer cravings, and lower overall caloric intake
Tirzepatide options (both injectable and oral) settle at $399 per month regardless of format
MASLD affects an estimated 25-30% of adults globally and is a leading cause of liver cirrhosis and liver cancer
Semaglutide targets the GLP-1 pathway, while tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone effect that may influence blood sugar, satiety, and fat metabolism more comprehensively
US$ 24.65
US$ 23.87
US$ 23.18
US$ 20.52
US$ 22.89
US$ 20.65
US$ 26.18
US$ 23.36
